计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| S646506-5mg |
5mg |
期货 ![]() |
| |
| S646506-10mg |
10mg |
期货 ![]() |
| |
| S646506-25mg |
25mg |
期货 ![]() |
| |
| S646506-50mg |
50mg |
期货 ![]() |
| |
| S646506-100mg |
100mg |
期货 ![]() |
|
| 英文别名 | Q7387038 | A937568 | Propanamide, 3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-, (2S)- | (2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide | 3b5r | C-31 | DTXSID7 |
|---|---|
| 规格或纯度 | ≥99% |
| 英文名称 | S-23 |
| 生化机理 | S-23 是一种口服活性选择性雄激素受体调节剂(SARM),其 K i 为 1.7 nM。S-23 能诱导 CV-1 细胞中雄激素受体(AR)介导的转录激活。S-23 可增加前列腺、精囊和阴茎背肌的重量。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
S-23 is an orally active selective androgen receptor modulator (SARM) with a K i of 1.7 nM. S-23 induces androgen receptor (AR)-mediated transcriptional activation in CV-1 cells. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats In Vitro S-23 induces AR-mediated transcriptional activation in CV-1 cells when used at a concentration of 10 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo By administration of S-23 to castrated animals, androgen-dependent organ weights increased in a dose-dependent manner. The ED 50 of S-23 in the prostate and levator ani muscle is 0.43 and 0.079 mg/d, respectively . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Sprague Dawley rats (in castrated male rats) Dosage: 0.01-3 mg Administration: S.c.; daily for 14 d Result: Androgen-dependent organ weights increased in a dose-dependent manner. At a dose rate as low as 0.1 mg/d, S-23 is able to selectively maintain the weight of the levator ani muscle at the intact control level, whereas its effects on the prostate and seminal vesicles are lower than 30% of those observed in intact controls. Form:Solid IC50& Target:Ki: 1.7 nM (Androgen receptor) |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | (2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide |
| INCHI | 1S/C18H13ClF4N2O3/c1-17(27,9-28-12-4-5-14(19)15(20)7-12)16(26)25-11-3-2-10(8-24)13(6-11)18(21,22)23/h2-7,27H,9H2,1H3,(H,25,26)/t17-/m0/s1 |
| InChi Key | SSFVOEAXHZGTRJ-KRWDZBQOSA-N |
| Smiles | CC(COC1=CC(=C(C=C1)Cl)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O |
| Isomeric SMILES | C[C@](COC1=CC(=C(C=C1)Cl)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O |
| 关联CAS | 1010396-29-8 |
| PubChem CID | 24892822 |
| MeSH Entry Terms | 1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline;1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride;1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, (+-)-isomer;6,7-dimethoxy-4-phenyl-1,2,3,4-tetrahydroisoquinolin |
| 分子量 | 416.75 |
| 溶解性 | DMSO : 100 mg/mL (239.95 mM; Need ultrasonic) |
|---|---|
| 分子量 | 416.800 g/mol |
| XLogP3 | 3.700 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 416.055 Da |
| 单同位素质量Monoisotopic Mass | 416.055 Da |
| 拓扑极表面积Topological Polar Surface Area | 82.400 Ų |
| 重原子数Heavy Atom Count | 28 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 611.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |